Literature DB >> 9487539

Evaluation of the proposed FDA pilot dose-response methodology for topical corticosteroid bioequivalence testing.

G J Singh, N Fleischer, L Lesko, R Williams.   

Abstract

Mesh:

Substances:

Year:  1998        PMID: 9487539     DOI: 10.1023/a:1011980115866

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  7 in total

1.  Is it possible to estimate the parameters of the sigmoid Emax model with truncated data typical of clinical studies?

Authors:  S Dutta; Y Matsumoto; W F Ebling
Journal:  J Pharm Sci       Date:  1996-02       Impact factor: 3.534

2.  Analysis of chromameter results obtained from corticosteroid-induced skin blanching. I: Manipulation of data.

Authors:  E W Smith; J M Haigh; R B Walker
Journal:  Pharm Res       Date:  1998-02       Impact factor: 4.200

3.  Evaluation of the proposed FDA pilot dose-response methodology for topical corticosteroid bioequivalence testing.

Authors:  P H Demana; E W Smith; R B Walker; J M Haigh; I Kanfer
Journal:  Pharm Res       Date:  1997-03       Impact factor: 4.200

4.  Potency classification of topical corticosteroids: modern perspectives.

Authors:  J Ashworth
Journal:  Acta Derm Venereol Suppl (Stockh)       Date:  1989

5.  'Vasoconstriction'--skin blanching--assay for glucocorticoids--a critique.

Authors:  V P Shah; C C Peck; J P Skelly
Journal:  Arch Dermatol       Date:  1989-11

Review 6.  Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.

Authors:  N H Holford; L B Sheiner
Journal:  Clin Pharmacokinet       Date:  1981 Nov-Dec       Impact factor: 6.447

7.  Comparative blanching activities of proprietary diflucortolone valerate topical preparations.

Authors:  G L Coleman; I Kanfer; J M Haigh
Journal:  Dermatologica       Date:  1978
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.